Advertising Open Access Journals
There is always advertising, though people may not be aware of it.
Advertising in today's world uses every possible
media to get its message across. The
advertising industry is made up of
advertising companies,
advertising agencies,
media carrying the ads, and a host of people like copy editors, visualizers, brand managers , researchers, creative heads, and designers who take it to the customer or receiver at the last mile. TV commercials are short ads developed and paid for by companies and organizations seeking to capture the audience of a television show or network program. Radio
advertising refers to spoken
advertising spots between music and other programs which are aired on radio channels. This method dates back to 1920, when it first aired commercial radio. More than 4 billion people use the internet as of today. This number is 300 per cent higher than in 2005. Point being that internet use is skyrocketing and it doesn't stop.
High Impact List of Articles
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Therapeutic area variability in the collection of data supporting protocol end points and objectives
Kenneth Getz & Stella Stergiopoulos
Clinical Trail Methodology: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Early vascular aging syndrome: background and proposed definitions
Peter Nilsson
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
-
Novel agents in Waldenstrom macroglobulinemia
Ghayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Therapeutic Prospective: Clinical Investigation
Relevant Topics in Clinical